Endo Health Solutions Inc. (Formerly Known as Endo Pharmaceuticals Holdings Inc.) Reports Third Quarter Financial Results and Updates 2012 Financial Guidance

November 5, 2012 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

CHADDS FORD, Pa., Nov. 5, 2012 /PRNewswire/ --

• Total quarterly revenues of $750 million, decreased 1 percent versus prior year
• Qualitest quarterly net sales increase by 12 percent versus prior year

Twitter
LinkedIn
Facebook
Email
Print